Where I see patients (1)
Selected research
- 
							Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy.
							Blood
 - 
							Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
							Expert opinion on investigational drugs
 - 
							Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma.
							Bone marrow transplantation